Williams & Novak’s iShares MSCI Emerging Markets ex China ETF EMXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.44M Buy
14,520
+110
+0.8% +$10.6K 0.85% 33
2026
Q2
$1.47M Hold
14,410
– – 0.98% 30
2026
Q1
$1.15M Hold
14,410
– – 0.86% 30
2025
Q4
$1.05M Sell
14,410
-600
-4% -$42.6K 0.79% 34
2025
Q3
$1.01M Sell
15,010
-519
-3% -$33.5K 0.78% 35
2025
Q2
$981K Sell
15,529
-413
-3% -$24K 0.83% 34
2025
Q1
$883K Buy
15,942
+33
+0.2% +$1.85K 0.86% 33
2024
Q4
$882K Sell
15,909
-1,007
-6% -$59.1K 0.85% 31
2024
Q3
$1.03M Sell
16,916
-864
-5% -$51.9K 0.96% 30
2024
Q2
$1.05M Buy
17,780
+670
+4% +$38.6K 0.98% 29
2024
Q1
$948K Hold
17,110
– – 1.08% 29
2023
Q4
$948K Buy
+17,110
New +$882K 1.08% 29

Other funds holding EMXC

Williams & Novak's EMXC Position: Q3 2026 in Review

Williams & Novak increased its iShares MSCI Emerging Markets ex China ETF (EMXC) stake by 0.76% in Q3 2026, buying an estimated $10.6K and bringing the position to 14,520 shares worth $1.44M. The position accounts for 0.85% of the portfolio, ranked #33.

Williams & Novak first reported a position in EMXC in Q4 2023 and has held it in 12 quarters since. The position peaked at $1.47M in Q2 2026. 356 funds tracked by Wall St. Rank hold EMXC as of Q3 2026.

  • Williams & Novak held 14,520 shares of iShares MSCI Emerging Markets ex China ETF worth $1.44M as of Q3 2026.
  • Williams & Novak bought 110 iShares MSCI Emerging Markets ex China ETF shares in Q3 2026, an estimated $10.6K.
  • iShares MSCI Emerging Markets ex China ETF made up 0.85% of Williams & Novak's portfolio in Q3 2026, its #33 holding.
  • Williams & Novak first reported a position in iShares MSCI Emerging Markets ex China ETF in Q4 2023 and has held it in 12 quarters since.
  • Williams & Novak's iShares MSCI Emerging Markets ex China ETF position peaked at $1.47M in Q2 2026.
  • 356 funds tracked by Wall St. Rank held iShares MSCI Emerging Markets ex China ETF as of Q3 2026.

Based on Williams & Novak's 13F filing for Q3 2026, filed 9 Oct 2026.